Utilizing multiomic advanced diagnostics to identify CDK4/6 inhibitor response predictors and a posttreatment multiomic signature for patients with ER+/HER2-metastatic breast cancer (SIDEOUT-3)
CANCER RESEARCH（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要